Results 261 to 270 of about 651,783 (359)

Pan-Cancer Analysis of Homologous Recombination Deficiency in Cell Lines. [PDF]

Cancer Res Commun
Dodson AE, Shenker S, Sullivan P, Nayak SU, Middleton C, McGuire M, Chipumuro E, Mishina Y, Tobin ER, Cadzow L, Wylie AA, Sangurdekar D.   +11 more
europepmc   +1 more source

Multiple origins of the human glycophorin Sta gene. Identification of hot spots for independent unequal homologous recombinations.

, 1991
Chi‐Hsiang Huang, Olga O. Blumenfeld
openalex   +1 more source

Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference [PDF]

, 1997
Wei Hu, E H Bowman, Krista A. Delviks, Vinay K. Pathak   +3 more
openalex   +1 more source

Mechanisms of enhancer‐driven oncogene activation

International Journal of Cancer, EarlyView.
Abstract An aggressive subtype of acute myeloid leukemia (AML) is caused by enhancer hijacking resulting in MECOM overexpression. Several chromosomal rearrangements can lead to this: the most common (inv(3)/t(3;3)) results in a hijacked GATA2 enhancer, and there are several atypical MECOM rearrangements involving enhancers from other hematopoietic ...
Joyce Vriend, Ruud Delwel, Dorien Pastoors   +2 more
wiley   +1 more source

Homologous recombination in Leishmania enriettii.

, 1991
James F. Tobin, Avraham Laban, Dyann F. Wirth   +2 more
openalex   +1 more source

Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination.

Molecules and Cells, 2017
S. Sivanand, Seth D. Rhoades, Qinqin Jiang, Joyce V. Lee, Joseph L. Benci, Jingwen Zhang, Salina Yuan, Isabella Viney, Steven Zhao, Alessandro Carrer, M. Bennett, A. Minn, A. Weljie, R. Greenberg, K. Wellen   +14 more
semanticscholar   +1 more source

Nationwide implementation and evaluation of the Tumor‐First workflow for genetic testing in ovarian carcinoma

International Journal of Cancer, EarlyView.
What's New? The Tumor‐First workflow is a genetic testing strategy developed to detect pathogenic variants in ovarian cancer risk genes. Recently implemented in the Netherlands, this workflow aims to stratify germline testing while providing information on the effectiveness of PARP inhibitor therapy.
Vera M. Witjes, Joanne A. de Hullu, Dorien M. A. Hermkens, Yvonne H. C. M. Smolders, Julie E. M. Swillens, Sarah‐Lotte Slob, Tjalling Bosse, Marian J. E. Mourits, Margreet G. E. M. Ausems, Tumor‐First Implementation Group, Marjolijn J. L. Ligtenberg, Nicoline Hoogerbrugge, Saskia A.G.M. Cillessen, Johan J.P. Gille, Fenne L. Komdeur, Constantijne H. Mom, Malou L.H. Snijders, J. Margriet Collée, Hendrikus J. Dubbink, Floris H. Groenendijk, Esther Korpershoek, Eva Maria Roes, Christi J. van Asperen, Katja N. Gaarenstroom, Rob B. van der Luijt, Nienke van der Stoep, Elisabeth M.P. Steeghs, Marinus J. Blok, Loes F.S. Kooreman, Edward M. Leter, Brigitte F.M. Slangen, Ernst Jan M. Speel, Hester van Boven, Willemien J. van Driel, Frans B.L. Hogervorst, Lizet E. van der Kolk, Efraim H. Rosenberg, Joost Bart, Lieke P.V. Berger, Arja ter Elst, Annemarie H. van der Hout, Refika Yigit, Anne M.L. Jansen, Wouter Koole, Johanna Krol‐Veraar, Wendy W.J. de Leng, Ronald P. Zweemer, Marjolijn J.L. Ligtenberg, Arjen R. Mensenkamp, Janneke H.M. Schuurs‐Hoeijmakers, Michiel Simons   +50 more
wiley   +1 more source

Prp19/CDC5L promotes gastric cancer via activation of the MAPK pathway-mediated homologous recombination. [PDF]

Int J Biol Sci
Qiu S, Wang F, Gao X, Guan W, Dai T, Yin L, Wang F, Sun J, Guo P, Wu H, Feng S, Tang C.   +11 more
europepmc   +1 more source

Comprehensive genetic and epigenetic characterization of Lynch‐like syndrome patients

International Journal of Cancer, EarlyView.
What's New? Lynch‐like syndrome is associated with development of colorectal cancer (CRC) with microsatellite instability and loss of expression of certain mismatch repair (MMR) genes, similar to Lynch syndrome, but unlike Lynch syndrome, the genetic cause of Lynch‐like syndrome (LLS) remains unknown.
Francesca Pirini, Luciano Calzari, Gianluca Tedaldi, Michela Tebaldi, Valentina Zampiga, Ilaria Cangini, Rita Danesi, Mila Ravegnani, Valentina Arcangeli, Alessandro Passardi, Elisabetta Petracci, Sara Bravaccini, Giorgia Marisi, Alessandra Viel, Daniela Barana, Monica Pedroni, Luca Roncucci, Daniele Calistri, Davide Gentilini   +18 more
wiley   +1 more source

Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair. [PDF]

Cell Commun Signal
Xiao Y, Wu Y, Wang Q, Li M, Deng C, Gu X.   +5 more
europepmc   +1 more source